Literature DB >> 34278739

Cell Analysis from Dried Blood Spots: New Opportunities in Immunology, Hematology, and Infectious Diseases.

Ines Ait Belkacem1,2, Noushine Mossadegh-Keller2, Penelope Bourgoin1, Isabelle Arnoux3, Marie Loosveld3, Pierre-Emmanuel Morange3,4, Thibaut Markarian3,4, Pierre Michelet4,5, Jean Marc Busnel1, Sandrine Roulland2, Franck Galland2, Fabrice Malergue1.   

Abstract

Blood cell analysis is a major pillar of biomedical research and healthcare. These analyses are performed in central laboratories. Rapid shipment from collection site to the central laboratories is currently needed because cells and biomarkers degrade rapidly. The dried blood spot from a fingerstick allows the preservation of cellular molecules for months but entire cells are never recovered. Here leucocyte elution is optimized from dried blood spots. Flow cytometry and mRNA expression profiling are used to analyze the recovered cells. 50-70% of the leucocytes that are dried on a polyester solid support via elution after shaking the support with buffer are recovered. While red blood cells lyse upon drying, it is found that the majority of leucocytes are preserved. Leucocytes have an altered structure that is improved by adding fixative in the elution buffer. Leucocytes are permeabilized, allowing an easy staining of all cellular compartments. Common immunophenotyping and mRNAs are preserved. The ability of a new biomarker (CD169) to discriminate between patients with and without Severe Acute Respiratory Syndrome induced by Coronavirus 2 (SARS-CoV-2) infections is also preserved. Leucocytes from blood can be dried, shipped, and/or stored for at least 1 month, then recovered for a wide variety of analyses, potentially facilitating biomedical applications worldwide.
© 2021 The Authors. Advanced Science published by Wiley-VCH GmbH.

Entities:  

Keywords:  analysis; cells; dried blood spots

Year:  2021        PMID: 34278739     DOI: 10.1002/advs.202100323

Source DB:  PubMed          Journal:  Adv Sci (Weinh)        ISSN: 2198-3844            Impact factor:   16.806


  1 in total

1.  Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome.

Authors:  Carmel Therese Harrington; Naz Al Hafid; Karen Ann Waters
Journal:  EBioMedicine       Date:  2022-05-06       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.